XML 25 R14.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-based Compensation
3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Stock-based compensation
On July 27, 2016, the Kinsale Capital Group, Inc. 2016 Omnibus Incentive Plan (the "2016 Incentive Plan") became effective. The 2016 Incentive Plan, which is administered by the Compensation, Nominating and Corporate Governance Committee of the Company's Board of Directors, provides for grants of stock options, restricted stock, restricted stock units and other stock-based awards to officers, employees, directors, independent contractors and consultants. The number of shares of common stock available for issuance under the 2016 Incentive Plan may not exceed 2,073,832.
The total compensation cost that has been charged against income for share-based compensation arrangements was $0.5 million and $0.2 million for the three months ended March 31, 2019 and 2018, respectively.
Restricted Stock Awards
During the first quarter of 2019, the Company granted restricted stock awards under the 2016 Incentive Plan. The restricted stock awards were valued on the date of grant and will vest over a one-year period. The fair value of restricted stock awards was determined based on the closing trading price of the Company’s shares on the grant date or, if no shares were traded on the grant date, the last preceding date for which there was a sale of shares. Except for restrictions placed on the transferability of restricted stock, holders of unvested restricted stock have full stockholder’s rights, including voting rights and the right to receive dividends. Unvested shares of restricted stock awards and accrued dividends, if any, are forfeited upon the termination of service to or employment with the Company.
A summary of all restricted stock activity under the equity compensation plans for the three months ended March 31, 2019 is as follows:
 
 
For the Three Months Ended
 March 31, 2019
 
 
Number of Shares
 
Weighted Average Grant Date Fair Value per Share
Non-vested outstanding at the beginning of the period
 
92,465

 
$
52.98

Granted
 
7,020

 
$
55.56

Vested
 
(6,666
)
 
$
45.00

Forfeited
 
(1,305
)
 
$
53.60

Non-vested outstanding at the end of the period
 
91,514

 
$
53.75


As of March 31, 2019, the Company had $3.9 million of total unrecognized stock-based compensation expense expected to be charged to earnings over a weighted-average period of 3.0 years.
Stock Options
On July 27, 2016, the Board of Directors approved, and the Company granted, 1,036,916 stock options with an exercise price equal to the Initial Public Offering price of $16.00 per share and a weighted-average grant-date fair value of $2.71 per share. The options have a maximum contractual term of 10 years and vest in 4 equal annual installments following the date of the grant.
The value of the options granted was estimated at the date of grant using the Black-Scholes pricing model using the following assumptions:
Risk-free rate of return
 
1.26
%
Dividend yield
 
1.25
%
Expected share price volatility(1)
 
18.50
%
Expected life in years(2)
 
6.3 years


(1)
Expected volatility was based on the Company’s competitors within the industry.
(2)
Expected life was calculated using the simplified method, which was an average of the contractual term of the option and its ordinary vesting period, as the Company did not have sufficient historical data for determining the expected term of our stock option awards.
A summary of option activity as of March 31, 2019, and changes during the period then ended is presented below:
 
 
Number of Shares
 
Weighted-average exercise price
 
Weighted-average remaining years of contractual term
 
Aggregate intrinsic value (in thousands)
Outstanding at January 1, 2019
 
804,303

 
$
16.00

 
 
 
 
Granted
 

 

 
 
 
 
Forfeited
 
(12,600
)
 
16.00

 
 
 
 
Exercised
 
(37,308
)
 
16.00

 
 
 
 
Outstanding at March 31, 2019
 
754,395

 
$
16.00

 
7.3
 
$
39,659

Exercisable at March 31, 2019
 
302,629

 
$
16.00

 
7.3
 
$
15,909


The total intrinsic value of options exercised was $1.9 million and $1.0 million during the three months ended March 31, 2019 and 2018, respectively. As of March 31, 2019, the Company had $0.8 million of total unrecognized stock-based compensation expense expected to be charged to earnings over a weighted-average period of 1.3 years.